Plasminogen activator inhibitor-1 is involved in streptozotocin-induced bone loss in female mice.
about
Application of VEGFA and FGF-9 enhances angiogenesis, osteogenesis and bone remodeling in type 2 diabetic long bone regenerationMiR-378 overexpression attenuates high glucose-suppressed osteogenic differentiation through targeting CASP3 and activating PI3K/Akt signaling pathway.Plasminogen activator inhibitor-1 is involved in impaired bone repair associated with diabetes in female mice.The Tissue Fibrinolytic System Contributes to the Induction of Macrophage Function and CCL3 during Bone Repair in MiceCardiovascular-renal complications and the possible role of plasminogen activator inhibitor: a review.Association of Plasminogen Activator Inhibitor-1 (PAI-1) Gene Polymorphisms with Osteoporotic Vertebral Compression Fractures (OVCFs) in Postmenopausal WomenRole of mesenchymal stem cell-derived fibrinolytic factor in tissue regeneration and cancer progression.Role of plasminogen activator inhibitor-1 in glucocorticoid-induced muscle change in mice.Tissue-type plasminogen activator deficiency delays bone repair: roles of osteoblastic proliferation and vascular endothelial growth factor.Plasminogen activator inhibitor-1 deficiency enhances subchondral osteopenia after induction of osteoarthritis in mice.Deletion of FoxO1, 3, and 4 in Osteoblast Progenitors Attenuates the Loss of Cancellous Bone Mass in a Mouse Model of Type 1 Diabetes.Identification of key genes influenced by fixation stability in early fracture hematoma and elucidation of their roles in fracture healing.Adipose Tissue-Derived Plasminogen Activator Inhibitor-1 Function and Regulation.A small-molecule PAI-1 inhibitor prevents bone loss by stimulating bone formation in a murine estrogen deficiency-induced osteoporosis model.
P2860
Q27312663-C60CA46E-AA16-4128-9104-63F96C384A16Q34502004-4FFBF4BF-A0CE-4B43-8B0A-D95AFAA6E871Q35126620-826695C0-7DC1-4268-9749-CD546EE2D92BQ35500642-2EDE20B7-F5D1-43A8-94D8-32603589C4CEQ37284133-B6C8632A-1170-4ACA-AA51-4FEC377FC5C7Q37534744-4EC4E99B-FB1D-4949-B309-BC8F5DFD9F5FQ38583085-09F1F523-585A-4FA0-87B7-2B2A61CE847DQ38891940-5F21EDDC-D3E1-4E1D-9DE5-5B1B4E6997AEQ38985924-A3348E7F-7F47-40B8-AB75-A460B62D7DA3Q41279300-CC2B3019-F95D-4D96-A670-A0263EEC665EQ47105930-7BD158AB-089D-43BD-A592-40283131D271Q47155974-1A681983-7015-4882-83A9-1E880DE98B30Q51361802-9400128B-AFC1-4B63-A14F-6C104D51CDE9Q52597483-2C2AD1F1-F074-4971-B87E-946B54D5C80A
P2860
Plasminogen activator inhibitor-1 is involved in streptozotocin-induced bone loss in female mice.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Plasminogen activator inhibito ...... uced bone loss in female mice.
@en
Plasminogen activator inhibito ...... uced bone loss in female mice.
@nl
type
label
Plasminogen activator inhibito ...... uced bone loss in female mice.
@en
Plasminogen activator inhibito ...... uced bone loss in female mice.
@nl
prefLabel
Plasminogen activator inhibito ...... uced bone loss in female mice.
@en
Plasminogen activator inhibito ...... uced bone loss in female mice.
@nl
P2093
P2860
P356
P1433
P1476
Plasminogen activator inhibito ...... uced bone loss in female mice.
@en
P2093
Hiroshi Kaji
Katsumi Okumoto
Kiyotaka Okada
Masato Yano
Naoyuki Kawao
Osamu Matsuo
Yukinori Tamura
P2860
P304
P356
10.2337/DB12-1552
P407
P577
2013-05-28T00:00:00Z